McKesson Ventures
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Announcing our latest investment led by Spectrum Equity and McKesson Ventures

by McKesson Ventures | Jan 19, 2022 | Media Coverage, Portfolio News

RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture...

Recent Posts

  • CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth
  • Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry
  • Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada
  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth

Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry

Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada

Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow